Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $114.0400 (2.46%) ($111.4700 - $114.3200) on Thu. Jun. 27, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 50 | Latest Price | $114.0400(2.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.055% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | 0 () | Intraday Trend | 1.6% | | | |
|
5 Day Moving Average | $111.33(2.43%) | 10 Day Moving Average | $111.65(2.14%) | 20 Day Moving Average | $111.65(2.14%) | To recent high | -11.8% | To recent low | 6.2% | Market Cap | $1.833b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |